Published in J Neuropathol Exp Neurol on December 01, 1997
Genetics of human hydrocephalus. J Neurol (2006) 1.36
Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia (2009) 1.26
Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol (2011) 1.22
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Role for complement in the development of seizures following acute viral infection. J Virol (2010) 0.94
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial? Am J Pathol (2007) 0.92
Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration. Pathophysiology (2011) 0.91
DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol (1999) 0.88
Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus. Future Virol (2011) 0.85
Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol (2007) 0.84
Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection. J Virol (2011) 0.83
Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis. J Neuroimaging (2015) 0.79
Picornavirus infection leading to immunosuppression. Future Virol (2014) 0.78
NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection. Exp Neurol (2016) 0.77
Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection. Cell Immunol (2015) 0.76
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability. Nutrition (2016) 0.75
DA virus mutant H101 has altered CNS pathogenesis and causes immunosuppression. J Neuroimmunol (2014) 0.75
Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis. Clin Exp Neuroimmunol (2016) 0.75
The Mouse Gene Expression Database (GXD). Nucleic Acids Res (2001) 4.44
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature (1979) 1.75
Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol (1996) 1.67
A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol (1989) 1.59
Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest (1986) 1.53
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol (1983) 1.46
Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol (1980) 1.45
Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology (1997) 1.41
Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J Virol (1988) 1.41
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J Virol (1989) 1.35
Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J Exp Med (1986) 1.24
Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol (2001) 1.21
The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol (1990) 1.20
Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis (1989) 1.19
Spread and distribution of viral antigen in nervous canine distemper. Acta Neuropathol (1985) 1.17
Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol (2000) 1.17
Sequence analysis and expression of the attachment and fusion proteins of canine distemper virus wild-type strain A75/17. J Virol (1999) 1.15
Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion. J Virol (2000) 1.14
Characterization of in vitro transcription and transcriptional products of measles virus. J Virol (1987) 1.14
Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med (1981) 1.13
Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol (1998) 1.11
Human monoclonal antibodies to myelin-associated glycoprotein. Comparison of specificity and use for immunocytochemical localisation of the antigen. J Neuroimmunol (1983) 1.10
Canine distemper virus clearance in chronic inflammatory demyelination. Acta Neuropathol (1986) 1.09
Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med (1990) 1.08
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology (1983) 1.07
Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol (1993) 1.07
A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res (2000) 1.07
A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP. J Biol Chem (2000) 1.05
Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol (1994) 1.05
Restricted infection with canine distemper virus leads to down-regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol (1995) 1.05
Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J Neuroimmunol (1988) 1.05
RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma. Gene Ther (2008) 1.05
Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol (1999) 1.04
Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol (1991) 1.03
Viruses can silently prime for and trigger central nervous system autoimmune disease. J Neurovirol (2001) 1.03
Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog Med Virol (1980) 1.02
Secondary degeneration of oligodendrocytes in canine distemper virus infection in vitro. Lab Invest (1986) 1.01
Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog (1995) 1.00
Demyelinating, non-demyelinating and attenuated canine distemper virus strains induce oligodendroglial cytolysis in vitro. J Neurol Sci (1987) 0.99
Neuropathological and aetiological studies of sporadic non-suppurative meningoencephalomyelitis of cattle. Vet Rec (1998) 0.98
Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol (1999) 0.98
The neurobiology of canine distemper virus infection. Vet Microbiol (1995) 0.98
Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants. J Immunol (1981) 0.98
Antigenic modulation induced by monoclonal antibodies: antibodies to measles virus hemagglutinin alters expression of other viral polypeptides in infected cells. J Immunol (1984) 0.97
Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol (1991) 0.96
Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol (2000) 0.96
Demyelinating polyneuropathy associated with monoclonal IgM-paraproteinaemia. Histological, ultrastructural and immunocytochemical studies. J Neurol Sci (1984) 0.96
Distemper: not a new disease in lions and tigers. Clin Diagn Lab Immunol (1997) 0.95
Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res (1991) 0.95
Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol (1993) 0.94
Studies on the intrathecal humoral immune response in canine distemper encephalitis. J Neuroimmunol (1986) 0.93
Molecular mimicry: a mechanism for autoimmune injury. FASEB J (1992) 0.93
In situ hybridization and immunohistochemistry for prion protein (PrP) in bovine spongiform encephalopathy (BSE). Zentralbl Veterinarmed A (1995) 0.93
Studies on canine distemper virus persistence in the central nervous system. Acta Neuropathol (1995) 0.92
Canine distemper virus does not infect oligodendrocytes in vitro. J Neurol Sci (1985) 0.92
Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol (1999) 0.91
Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression. Virology (1997) 0.91
Purification of measles virus glycoproteins and their integration into artificial lipid membranes. J Gen Virol (1981) 0.91
Morphological and immunocytochemical characterisation of mixed glial cell cultures derived from neonatal canine brain. Res Vet Sci (1984) 0.91
A monoclonal antibody that binds to both astrocytes and myelin sheaths. J Neuroimmunol (1985) 0.90
Canine distemper virus increases procoagulant activity of macrophages. Virology (1992) 0.90
Targeted screening of high-risk cattle populations for BSE to augment mandatory reporting of clinical suspects. Prev Vet Med (2001) 0.90
Loss of virulence of canine distemper virus is associated with a structural change recognized by a monoclonal antibody. Experientia (1991) 0.90
Immunohistochemical demonstration of the putative canine distemper virus receptor CD150 in dogs with and without distemper. Vet Pathol (2007) 0.89
Serologic relatedness between Thy-1.2 and actin revealed by monoclonal antibody. J Immunol (1983) 0.89
Myelin-associated glycoprotein is produced before myelin basic protein in cultured oligodendrocytes. J Neuroimmunol (1984) 0.88
DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol (1999) 0.88
In vivo and in vitro detection of canine distemper virus nucleoprotein gene with digoxigenin-labelled RNA, double-stranded DNA probes and oligonucleotides by in situ hybridization. Zentralbl Veterinarmed B (1997) 0.88
Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals. Lab Invest (1977) 0.87
Cellular transfer of experimental allergic encephalomyelitis employing suckling and adult Lewis rats. J Clin Lab Immunol (1981) 0.87
Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology (1998) 0.86
[Swiss scrapie surveillance. I. Clinical aspects of neurological diseases in sheep and goats]. Schweiz Arch Tierheilkd (2005) 0.86
GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings. Vet Pathol (2001) 0.86
Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen. J Immunol (1977) 0.86
Expression of TNF alpha in arthritis caused by caprine arthritis encephalitis virus. Vet Immunol Immunopathol (1996) 0.86
Canine distemper virus-induced glial cell changes in vitro. Acta Neuropathol (1983) 0.85
Generation and functional characterisation of canine bone marrow-derived macrophages. Res Vet Sci (1998) 0.85
Abundant expression of viral nucleoprotein mRNA and restricted translation of the corresponding viral protein in inclusion body polioencephalitis of canine distemper. J Comp Pathol (1997) 0.85
Comparison of inducible nitric oxide synthase expression in the brains of Listeria monocytogenes-infected cattle, sheep, and goats and in macrophages stimulated in vitro. Infect Immun (1997) 0.85
Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine (1999) 0.85